Clinical Trials for Renal Cell Cancer

Find clinical trials for renal cell cancer. Discover research opportunities and treatment options in your area.

17 Active Trials Found

Showing 17 trials on this page

Page 1 of 1

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

NCT ID: NCT02830724

This clinical trial is testing a new treatment for certain types of cancer, including pancreatic, renal cell, breast, melanoma, and ovarian cancers, that express a protein called CD70. The treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation Study

NCT ID: NCT07020169

This clinical trial is exploring how a new artificial intelligence (AI) tool can help surgeons during a type of kidney surgery called partial nephrectomy, which is used to remove part of the kidney...

Recruiting

Phase: NA Type: interventional Locations: Nanjing, Jiangsu, China

Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma

NCT ID: NCT06934057

This clinical trial is studying the use of two medications, Cabozantinib and Nivolumab, in older patients with a specific type of kidney cancer called metastatic clear-cell renal cell carcinoma. Th...

Not yet recruiting

Phase: PHASE4 Type: interventional Locations: Dijon, , France, Paris, , France +5 more

The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study

NCT ID: NCT06751498

This clinical trial is looking at a new way to predict how well a person's kidneys will function after they have surgery to remove part of a kidney due to kidney cancer. Researchers are using a spe...

Recruiting

Type: observational Locations: Nanjing, Jiangsu, China, Nanjing, Jiangsu, China

TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors

NCT ID: NCT04969315

This clinical trial is investigating two new treatments, called TT-10 and TT-4, both alone and in combination, for patients with advanced solid tumors like kidney cancer, prostate cancer, lung canc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Louisville, Kentucky, United States +7 more

Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

NCT ID: NCT06903312

This clinical trial is designed to investigate whether treating the primary kidney tumor in patients with metastatic renal cell carcinoma (mRCC) who are responding well to immunotherapy can help th...

Not yet recruiting

Phase: PHASE4 Type: interventional

Optimising Renal Tumour Management Through Artificial Intelligence Modules

NCT ID: NCT06714916

This clinical trial is studying how artificial intelligence (AI) can help improve the care of patients with kidney tumors, which can be benign (not cancerous) or malignant (cancerous). The trial ai...

Recruiting

Type: observational Locations: Nanjing, Jiangsu, China

Prehabilitation Prior to Surgery for Kidney Tumors

NCT ID: NCT06745609

This clinical trial is studying whether taking one month to improve overall health before surgery for kidney tumors can help patients recover faster and feel better afterward. This process, called ...

Recruiting

Phase: NA Type: interventional Locations: Herlev, , Denmark

Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma

NCT ID: NCT06773377

This clinical trial is looking at a specific protein called CD44 and its role in renal cell carcinoma (RCC), a type of kidney cancer. Researchers want to understand how CD44 is expressed in differe...

Not yet recruiting

Type: observational

A Study of IBI363 in Subjects with Advanced Solid Malignancies

NCT ID: NCT06281678

This clinical trial is studying a new drug called IBI363 to see how well it works in treating patients with advanced solid tumors, which are types of cancers that form in tissues like organs. This ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Ocala, Florida, United States, Seattle, Washington, United States +8 more

A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy

NCT ID: NCT06362369

This clinical trial is testing a new medication called Alintegimod, taken by mouth, in combination with two other treatments for patients with advanced cancers, such as melanoma, kidney cancer, and...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Lebanon, New Hampshire, United States +1 more

Vorolanib in the Second-line Treatment of Patients with Unresectable or Metastatic Renal Cell Carcinoma

NCT ID: NCT06676527

This clinical trial is investigating the effectiveness of a medication called vorolanib for patients with advanced kidney cancer that cannot be surgically removed or has spread to other parts of th...

Recruiting

Type: observational Locations: Nanjing, Jiangsu, China

Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors

NCT ID: NCT04258462

This clinical trial is looking at a new way to use a special type of MRI scan called hyperpolarized 13C pyruvate MRI to help doctors understand how aggressive kidney tumors might be. The goal is to...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Francisco, California, United States

WIRE - Novel Treatments in Renal Cell Cancer

NCT ID: NCT03741426

The WIRE trial is researching new treatments for renal cell cancer, specifically focusing on how three different investigational medications work when given alone or in combination. This study will...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cambridge, England, United Kingdom, Cambridge, , United Kingdom +1 more

Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome

NCT ID: NCT04625556

This clinical trial is studying how the microbiome—tiny living organisms in our bodies—can help in understanding and treating urological cancers like prostate, renal cell, bladder, and ureter cance...

Recruiting

Type: observational Locations: Seoul, , Korea, Republic Of

Modi-1 in Breast, Head and Neck, Ovarian, or Renal Cancer

NCT ID: NCT05329532

This clinical trial is studying a new vaccine called Modi-1, which is being tested to see how safe and effective it is for patients with certain types of advanced cancers, including triple negative...

Recruiting

Phase: PHASE1 Type: interventional Locations: Brighton, Default, United Kingdom, Bristol, Default, United Kingdom +12 more

Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA

NCT ID: NCT04197414

This clinical trial is focused on studying how circulating tumor DNA (ctDNA) can help in the diagnosis and monitoring of urological cancers, such as prostate, renal cell, bladder, and ureter cancer...

Recruiting

Type: observational Locations: Seoul, , Korea, Republic Of

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions